TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | -23.7% | 11,637 | -22.2% | 0.00% | – |
| Q2 2023 | $270 | +47.5% | 14,956 | +3.0% | 0.00% | – |
| Q1 2023 | $183 | +57.8% | 14,515 | +83.3% | 0.00% | – |
| Q4 2022 | $116 | -99.8% | 7,918 | +110.5% | 0.00% | – |
| Q3 2022 | $64,000 | +12.3% | 3,761 | -3.4% | 0.00% | – |
| Q2 2022 | $57,000 | +29.5% | 3,892 | +50.1% | 0.00% | – |
| Q1 2022 | $44,000 | – | 2,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |